CAPACI, VALERIA
 Distribuzione geografica
Continente #
NA - Nord America 438
EU - Europa 203
AS - Asia 155
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 3
Totale 807
Nazione #
US - Stati Uniti d'America 437
SG - Singapore 60
IT - Italia 50
CN - Cina 43
SE - Svezia 41
HK - Hong Kong 32
UA - Ucraina 20
RU - Federazione Russa 17
BG - Bulgaria 16
DE - Germania 14
FI - Finlandia 12
BE - Belgio 9
TR - Turchia 9
IE - Irlanda 7
AT - Austria 5
NL - Olanda 4
SN - Senegal 4
VN - Vietnam 4
BR - Brasile 3
GB - Regno Unito 3
IN - India 3
KR - Corea 3
CH - Svizzera 2
CZ - Repubblica Ceca 2
EU - Europa 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CA - Canada 1
HU - Ungheria 1
LK - Sri Lanka 1
MA - Marocco 1
Totale 807
Città #
Chandler 63
Fairfield 40
Singapore 37
Woodbridge 37
Ashburn 35
Houston 33
Hong Kong 32
Ann Arbor 28
Trieste 27
Wilmington 23
Seattle 21
Jacksonville 20
Sofia 16
Boardman 13
Cambridge 13
Princeton 12
Columbus 10
Beijing 9
Santa Clara 9
Brussels 8
Izmir 8
Dublin 7
Los Angeles 7
Helsinki 6
Moscow 6
Dakar 4
Dong Ket 4
Falls Church 4
Jinan 4
Vienna 4
Amsterdam 3
Bremen 3
San Mateo 3
Seoul 3
Shanghai 3
São Paulo 3
Washington 3
Brno 2
Caserta 2
Des Moines 2
Munich 2
Nuremberg 2
Pignone 2
Pune 2
Ancona 1
Batley 1
Bern 1
Budapest 1
Buffalo 1
Calcinate 1
Colombo 1
Dearborn 1
Düsseldorf 1
Frankfurt am Main 1
Grafing 1
Halle 1
Hefei 1
Indiana 1
Kunming 1
Langfang 1
Lausanne 1
London 1
Maserada sul Piave 1
Milan 1
Norwalk 1
Phoenix 1
Rome 1
Sacile 1
San Diego 1
Schio 1
Shenyang 1
Toronto 1
Wuhan 1
Wuxi 1
Xi'an 1
Totale 606
Nome #
A Pin1/mutant p53 axis promotes aggressiveness in breast cancer. 173
The cytoplasmic side of p53's oncosuppressive activities 165
Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer. 151
Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome 103
A mutant p53/Hif1α/miR-30d axis reprograms the secretory pathway promoting the release of a prometastatic secretome 93
ETV6-related thrombocytopenia: dominant negative effect of mutations as common pathogenic mechanism 64
A Targeted Proteomics Approach for Screening Serum Biomarkers Observed in the Early Stage of Type I Endometrial Cancer 38
The Deep Proteomics Approach Identified Extracellular Vesicular Proteins Correlated to Extracellular Matrix in Type One and Two Endometrial Cancer 38
A novel mutation in MECOM affects MPL regulation in vitro and results in thrombocytopenia and bone marrow failure 26
A Multi-Omics Approach Revealed Common Dysregulated Pathways in Type One and Type Two Endometrial Cancers 2
Totale 853
Categoria #
all - tutte 3.008
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.008


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202019 0 0 0 0 0 0 0 0 7 5 7 0
2020/202186 7 0 6 3 10 24 3 4 7 6 9 7
2021/202293 3 1 7 7 5 12 4 4 9 4 9 28
2022/2023168 13 27 17 25 12 32 0 17 14 0 9 2
2023/202499 4 2 6 7 8 18 17 18 3 1 6 9
2024/2025185 7 12 29 32 25 26 12 14 28 0 0 0
Totale 853